171 related articles for article (PubMed ID: 21764604)
1. Selecting patients for heart transplantation: comparison of the Heart Failure Survival Score (HFSS) and the Seattle heart failure model (SHFM).
Goda A; Williams P; Mancini D; Lund LH
J Heart Lung Transplant; 2011 Nov; 30(11):1236-43. PubMed ID: 21764604
[TBL] [Abstract][Full Text] [Related]
2. Comparison of peak exercise oxygen consumption and the Heart Failure Survival Score for predicting prognosis in women versus men.
Green P; Lund LH; Mancini D
Am J Cardiol; 2007 Feb; 99(3):399-403. PubMed ID: 17261406
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of the addition of peak oxygen consumption to the Seattle Heart Failure Model in a transplant referral population.
Levy WC; Aaronson KD; Dardas TF; Williams P; Haythe J; Mancini D
J Heart Lung Transplant; 2012 Aug; 31(8):817-24. PubMed ID: 22759798
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of peak exercise oxygen consumption and the heart failure survival score to predict survival in patients >65 years of age with heart failure.
Parikh MN; Lund LH; Goda A; Mancini D
Am J Cardiol; 2009 Apr; 103(7):998-1002. PubMed ID: 19327430
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide.
May HT; Horne BD; Levy WC; Kfoury AG; Rasmusson KD; Linker DT; Mozaffarian D; Anderson JL; Renlund DG
Am J Cardiol; 2007 Aug; 100(4):697-700. PubMed ID: 17697831
[TBL] [Abstract][Full Text] [Related]
6. Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure.
Lund LH; Aaronson KD; Mancini DM
Am J Cardiol; 2005 Mar; 95(6):734-41. PubMed ID: 15757599
[TBL] [Abstract][Full Text] [Related]
7. Selection of patients for heart transplantation in the current era of heart failure therapy.
Butler J; Khadim G; Paul KM; Davis SF; Kronenberg MW; Chomsky DB; Pierson RN; Wilson JR
J Am Coll Cardiol; 2004 Mar; 43(5):787-93. PubMed ID: 14998618
[TBL] [Abstract][Full Text] [Related]
8. Is it time for a cardiac allocation score? First results from the Eurotransplant pilot study on a survival benefit-based heart allocation.
Smits JM; de Vries E; De Pauw M; Zuckermann A; Rahmel A; Meiser B; Laufer G; Reichenspurner H; Strueber M
J Heart Lung Transplant; 2013 Sep; 32(9):873-80. PubMed ID: 23628111
[TBL] [Abstract][Full Text] [Related]
9. Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving beta-blockers.
Koelling TM; Joseph S; Aaronson KD
J Heart Lung Transplant; 2004 Dec; 23(12):1414-22. PubMed ID: 15607672
[TBL] [Abstract][Full Text] [Related]
10. Prediction of mode of death in heart failure: the Seattle Heart Failure Model.
Mozaffarian D; Anker SD; Anand I; Linker DT; Sullivan MD; Cleland JG; Carson PE; Maggioni AP; Mann DL; Pitt B; Poole-Wilson PA; Levy WC
Circulation; 2007 Jul; 116(4):392-8. PubMed ID: 17620506
[TBL] [Abstract][Full Text] [Related]
11. Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for heart transplantation.
Sartipy U; Goda A; Yuzefpolskaya M; Mancini DM; Lund LH
Am Heart J; 2014 Sep; 168(3):325-31. PubMed ID: 25173544
[TBL] [Abstract][Full Text] [Related]
12. Superiority of the heart failure survival score to peak exercise oxygen consumption in the prediction of outcomes in an independent population referred for heart transplant evaluation.
Bobbio M; Dogliani S; Giacomarra G
Ital Heart J; 2004 Dec; 5(12):899-905. PubMed ID: 15706994
[TBL] [Abstract][Full Text] [Related]
13. Validation of mortality risk stratification models for cardiovascular disease.
Nakayama M; Osaki S; Shimokawa H
Am J Cardiol; 2011 Aug; 108(3):391-6. PubMed ID: 21600539
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison.
Agostoni P; Paolillo S; Mapelli M; Gentile P; Salvioni E; Veglia F; Bonomi A; Corrà U; Lagioia R; Limongelli G; Sinagra G; Cattadori G; Scardovi AB; Metra M; Carubelli V; Scrutinio D; Raimondo R; Emdin M; Piepoli M; Magrì D; Parati G; Caravita S; Re F; Cicoira M; Minà C; Correale M; Frigerio M; Bussotti M; Oliva F; Battaia E; Belardinelli R; Mezzani A; Pastormerlo L; Guazzi M; Badagliacca R; Di Lenarda A; Passino C; Sciomer S; Zambon E; Pacileo G; Ricci R; Apostolo A; Palermo P; Contini M; Clemenza F; Marchese G; Gargiulo P; Binno S; Lombardi C; Passantino A; Filardi PP
Eur J Heart Fail; 2018 Apr; 20(4):700-710. PubMed ID: 28949086
[TBL] [Abstract][Full Text] [Related]
15. Utility of the Seattle Heart Failure Model in patients with advanced heart failure.
Kalogeropoulos AP; Georgiopoulou VV; Giamouzis G; Smith AL; Agha SA; Waheed S; Laskar S; Puskas J; Dunbar S; Vega D; Levy WC; Butler J
J Am Coll Cardiol; 2009 Jan; 53(4):334-42. PubMed ID: 19161882
[TBL] [Abstract][Full Text] [Related]
16. Four-variable risk model in men and women with heart failure.
Chyu J; Fonarow GC; Tseng CH; Horwich TB
Circ Heart Fail; 2014 Jan; 7(1):88-95. PubMed ID: 24281135
[TBL] [Abstract][Full Text] [Related]
17. Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee.
Gorodeski EZ; Chu EC; Chow CH; Levy WC; Hsich E; Starling RC
Circ Heart Fail; 2010 Nov; 3(6):706-14. PubMed ID: 20798278
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of risk indices in continuous-flow left ventricular assist device patients.
Schaffer JM; Allen JG; Weiss ES; Patel ND; Russell SD; Shah AS; Conte JV
Ann Thorac Surg; 2009 Dec; 88(6):1889-96. PubMed ID: 19932256
[TBL] [Abstract][Full Text] [Related]
19. Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy?
Levy WC; Mozaffarian D; Linker DT; Farrar DJ; Miller LW;
J Heart Lung Transplant; 2009 Mar; 28(3):231-6. PubMed ID: 19285613
[TBL] [Abstract][Full Text] [Related]
20. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.
Rothenburger M; Wichter T; Schmid C; Stypmann J; Tjan TD; Berendes E; Etz C; Pioux A; Löher A; Wenzelburger F; Drees G; Hoffmeier A; Breithardt G; Scheld HH
J Heart Lung Transplant; 2004 Oct; 23(10):1189-97. PubMed ID: 15477114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
